SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
95.90
0.00 (0.00%)
Feb 21, 2025, 1:30 PM CST
SYN-TECH Chem. & Pharm. Revenue
SYN-TECH Chem. & Pharm. had revenue of 330.58M TWD in the quarter ending September 30, 2024, with 0.06% growth. This brings the company's revenue in the last twelve months to 1.22B, up 11.41% year-over-year. In the year 2023, SYN-TECH Chem. & Pharm. had annual revenue of 1.11B with 13.02% growth.
Revenue (ttm)
1.22B
Revenue Growth
+11.41%
P/S Ratio
3.52
Revenue / Employee
5.52M
Employees
220
Market Cap
4.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.11B | 128.39M | 13.02% |
Dec 31, 2022 | 986.30M | 93.07M | 10.42% |
Dec 31, 2021 | 893.23M | -90.56M | -9.20% |
Dec 31, 2020 | 983.79M | 37.38M | 3.95% |
Dec 31, 2019 | 946.41M | 161.58M | 20.59% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Lotus Pharmaceutical | 17.59B |
Lumosa Therapeutics | 37.82M |
Oneness Biotech | 112.20M |
Polaris Group | 75.65M |
Pegavision | 7.06B |